EVERSANA buys digital drug-price marketplace firm Waltz Health

Pharma commercialisation services provider EVERSANA (pharmaphorum's parent company) has acquired Waltz Health, a Chicago digital health company offering AI-driven marketplaces to lower overall drug costs. The terms of the deal were not disclosed.

As part of the deal, Waltz Health CEO and co-founder Mark Thierer - who has previously led OptumRx and Catamaran - will become CEO of EVERSANA. Outgoing CEO Jim Lang will continue to serve on EVERSANA's Board of Directors.